Patients' attitudes about the use of placebo treatments: telephone survey

Sara Chandros Hull, Luana Colloca, Andrew Avins, Nancy P Gordon, Carol P Somkin, Ted J Kaptchuk, Franklin G Miller, Sara Chandros Hull, Luana Colloca, Andrew Avins, Nancy P Gordon, Carol P Somkin, Ted J Kaptchuk, Franklin G Miller

Abstract

Objective: To examine the attitudes of US patients about the use of placebo treatments in medical care.

Design: One time telephone surveys.

Setting: Northern California.

Participants: 853 members of Kaiser Permanente Northern California, aged 18-75, who had been seen by a primary care provider for a chronic health problem at least once in the prior six months.

Results: The response rate was 53.4% (853/1598) of all members who were eligible to participate, and 73.2% (853/1165) of all who could be reached by telephone. Most respondents (50-84%) judged it acceptable for doctors to recommend placebo treatments under conditions that varied according to doctors' level of certainty about the benefits and safety of the treatment, the purpose of the treatment, and the transparency with which the treatment was described to patients. Only 21.9% of respondents judged that it was never acceptable for doctors to recommend placebo treatments. Respondents valued honesty by physicians regarding the use of placebos and believed that non-transparent use could undermine the relationship between patients and physicians.

Conclusions: Most patients in this survey seemed favorable to the idea of placebo treatments and valued honesty and transparency in this context, suggesting that physicians should consider engaging with patients to discuss their values and attitudes about the appropriateness of using treatments aimed at promoting placebo responses in the context of clinical decision making.

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, and no other relationships or activities that could appear to have influenced the submitted work.

References

    1. Nizan U, Lichenberg P. Questionnaire survey on use of placebo. BMJ 2004;329:944-6.
    1. Kermen R, Hickner J, Brody H, Hasham I. Family physicians believe the placebo effect is therapeutic but often use real drugs as placebos. Fam Med 2010;42:636-42.
    1. Fassler M, Meissner K, Schneider A, Linde K. Frequency and circumstance of placebo use in clinical practice—a systematic review of empirical studies. BMC Med 2010;8:15-24.
    1. Tilburt JC, Emanuel EJ, Kaptchuk TJ, Curlin FA, Miller FG. Prescribing ‘placebo treatments’: results of a national survey of US internists and rheumatologists, BMJ 2008;337:a1938.
    1. Louhiala P. What do we really know about the deliberate use of placebos in clinical practice. J Med Ethics 2012;38:403-5.
    1. Colloca L, Miller FG. Harnessing the placebo effect: the need for translational research. Phil Trans Soc B 2011;366:1922-30.
    1. O’Neill O. Paternalism and partial autonomy. J Med Ethics 1984;10:173-8.
    1. Brody H. The lie that heals: the ethics of giving placebos. Ann Intern Med 1982;97:112-8.
    1. Miller FG, Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics. Am J Bioeth 2009;9:39-47.
    1. American Medical Association. American Medical Association Code of Medical Ethics, Opinion 8.083: Placebo Use in Clinical Practice. 2007. .
    1. Boozang KM. The therapeutic placebo: the case for patient deception. Fla Law Rev 2002;54:687-746.
    1. Kolber A. A limited defense of clinical placebo deception. Yale Law Policy Rev 2007;26:75-134.
    1. Finniss DG, Kaptchuk TJ, Miller FG, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet 2010;375:686-95.
    1. Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One 2010;5:e15591.
    1. Bishop FL, Jacobson EE, Shaw J, Kaptchuk TJ. Scientific tools, fake treatments or triggers for psychological healing: how RCT participants conceptualize placebos. Soc Sci Med 2012;8:1138-49.
    1. Chen GF, Johnson MH. Patients’ attitudes to the use of placebos: results from a New Zealand survey. N Z Med J 2009;122:35-46.
    1. Berthelot JM, Maugars Y, Abgrall M, Prost A. Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses. Joint Bone Spine 2001;68:65-70.
    1. Lynoe N, Mattsson B, Sandlund M. The attitudes of patients and physicians towards placebo treatment—a comparative study. Soc Sci Med 1993;36:767-74.
    1. Gordon NP. Similarity of the adult Kaiser Permanente membership in Northern California to the insured and general population in Northern California: statistics from the 2009 California Health Interview Survey. Internal Division of Research Report. 2012. Kaiser Permanente Division of Research. .
    1. Fassler M, Gnadinger M, Rosemann T, Biller-Andorno N. Placebo interventions in practice: a questionnaire survey on the attitudes of patients and physicians. Br J Gen Pract 2011;61:101-7.
    1. Hrobjartsson A, Norup M. The use of placebo interventions in medical practice—a national questionnaire survey of Danish clinicians. Eval Health Prof 2003;26:153-65.
    1. Brody H, Colloca L, Miller FG. The placebo phenomenon: implications for the ethics of shared decisionmaking. J Gen Intern Med 2012;27:739-42.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する